Paris, France

Jean-Robert Labrosse

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Robert Labrosse. Retrieved from https://idiyas.com/inventor/jean-robert-labrosse-65kyb6ea

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jean-Robert Labrosse: Innovator in Pharmaceutical Chemistry

Introduction

Jean-Robert Labrosse is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on pyrimidinone derivatives.

Latest Patents

Labrosse holds a patent for "Pyrimidinone derivatives, preparation thereof and pharmaceutical use thereof." This invention relates to novel products of formula (Ia) or (Ib), showcasing his expertise in developing new pharmaceutical compounds.

Career Highlights

Labrosse is associated with Sanofi, a leading global healthcare company. His work at Sanofi emphasizes his commitment to advancing medical science and improving patient outcomes through innovative drug development.

Collaborations

He has collaborated with notable colleagues, including Youssef El Ahmad and Jacques Clement, which highlights the collaborative nature of research and innovation in the pharmaceutical industry.

Conclusion

Jean-Robert Labrosse's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…